Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramlintide and Insulin in Dual-hormone Artificial Pancreas for Type 1 Diabetes
NCT04243629Unknown
- Sponsor
- McGill University
- Start
- Nov 2021
- Primary completion
- Apr 2024
- Countries
- 1
01
Overview
Randomised, double-blind trial of pramlintide in type 1 diabetes mellitus (T1D), sponsored by McGill University. Primary endpoint: Time in target range at 4 weeks. Status: unknown.
02
Drugs
pramlintide
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04243629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04243629.